Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase ... - Forbes

by Hgh @ Sat, 14 Jun 2008 03:00:04 -0400
NUTLEY, N.J., June 10 /PRNewswire/ -- Roche and Ipsen's investigational type 2 diabetes drug taspoglutide (R1583) has been shown to provide significant improvements in glucose control and weight loss after only eight weeks of treatment(1,2) with a ...
  • Recent posts: